GLO1 overexpression in human malignant melanoma
By: Bair WB 3rd, Cabello CM, Uchida K, Bause AS, Wondrak GT.

Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, USA Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Melanoma Res. 2010 Jan 20.

Abstract

Glyoxalase I [lactoylglutathione lyase (EC 4.4.1.5) encoded by GLO1] is a ubiquitous cellular defense enzyme involved in the detoxification of methylglyoxal, a cytotoxic byproduct of glycolysis. Accumulative evidence suggests an important role of GLO1 expression in protection against methylglyoxal−dependent protein adduction and cellular damage associated with diabetes, cancer, and chronological aging. On the basis of the hypothesis that GLO1 upregulation may play a functional role in glycolytic adaptations of cancer cells, we examined GLO1 expression status in human melanoma tissue. Quantitative reverse transcription polymerase chain reaction analysis of a cDNA tissue array containing 40 human melanoma tissues (stages III and IV) and 13 healthy controls revealed pronounced upregulation of GLO1 expression at the mRNA level. Immunohistochemical analysis of a melanoma tissue microarray confirmed upregulation of glyoxalase I protein levels in malignant melanoma tissue versus healthy human skin. Consistent with an essential role of GLO1 in melanoma cell defense against methylglyoxal cytotoxicity, siRNA interference targeting GLO1−expression (siGLO1) sensitized A375 and G361 human metastatic melanoma cells towards the antiproliferative, apoptogenic, and oxidative stress−inducing activity of exogenous methylglyoxal. Protein adduction by methylglyoxal was increased in siGLO1−transfected cells as revealed by immunodetection using a monoclonal antibody directed against the major methylglyoxal−derived epitope argpyrimidine that detected a single band of methylglyoxal−adducted protein in human LOX, G361, and A375 total cell lysates. Using two−dimensional proteomics followed by mass spectrometry the methylglyoxal−adducted protein was identified as heat shock protein 27 (Hsp27; HSPB1). Taken together, our data suggest a function of GLO1 in the regulation of detoxification and target adduction by the glycolytic byproduct methylglyoxal in malignant melanoma.

PMID: 20093988 [PubMed − as supplied by publisher] Source: National Library of Medicine.






* Albert Einstein College of Medicine has been
awarded Acceditation with Commendation by
the ACCME

Copyright 2024 InterMDnet | Privacy Policy | Disclaimer | System Requirements